Evidence map›Paper›PMID 24746994›Full record

ArticleThe Journal of thoracic and cardiovascular surgery2014

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases.

Bo Deng, Stephen D Cassivi, Mariza de Andrade, Francis C Nichols, Victor F Trastek, Yi Wang, Jason A Wampfler, Shawn M Stoddard, Dennis A Wigle, Robert K Shen and 3 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of thoracic and cardiovascular surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 3 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 3 syntheses or guidelines pooled it, 66 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Segmentectomy versus lobectomy. Which factors are decisive for an optimal oncological outcome?Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2023
    Review
  14. Systematic review and meta-analysis of segmentectomyJournal of thoracic disease · 2023
    Article
  15. Review
  16. National trends in the quality of segmentectomy for lung cancer.The Journal of thoracic and cardiovascular surgery · 2023
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Bo DengDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn; Department of Thoracic Surgery, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Stephen D CassiviDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Mariza de AndradeDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn.
Francis C NicholsDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Victor F TrastekDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Yi WangDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn; School of Environmental Science and Public Health, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Jason A WampflerDivision of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn.
Shawn M StoddardDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn.
Dennis A WigleDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Robert K ShenDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Mark S AllenDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Claude DeschampsDivision of General Thoracic Surgery, Department of Surgery, Mayo Clinic College of Medicine, Rochester, Minn.
Ping YangDivision of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, Minn. Electronic address: yang.ping@mayo.edu.
Department of Medical Sciences · BYArmy Medical University · CNMayo Clinic · USWenzhou Medical University · CN

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
ALPHA 1 AD CARRIERS AND LUNG CANCER RISKR01CA080127 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2000 to 2009
$4.4M
Genetic Determinants of Lung Cancer SurvivalR01CA084354 · NCI · MAYO CLINIC ROCHESTER · PI YANG, PING · 2001 to 2012
$4.0M
DEVELOPMENT OF LUNG CANCER EPIDEMIOLOGY RESEARCHR03CA077118 · NCI · MAYO CLINIC COLL OF MEDICINE, ROCHESTER · PI YANG, PING · 1997 to 1998
–
NCI NIH HHS P30 CA015083NCI NIH HHS R01 CA080127NCI NIH HHS R01 CA084354NCI NIH HHS R01 CA80127NCI NIH HHS R01 CA84354NCI NIH HHS R03 CA077118NCI NIH HHS R03 CA77118
6 · The paper itself

Abstract

objectiveWe compared the clinical outcomes and changes in pulmonary function test (PFT) results after segmentectomy or lobectomy for non-small cell lung cancer.

methodsThe retrospective study included 212 patients who had undergone segmentectomy (group S) and 2336 patients who had undergone lobectomy (group L) from 1997 to 2012. The follow-up and medical record data were collected. We used all the longitudinal PFT data within 24 months postoperatively and performed linear mixed modeling. We analyzed the 5-year overall and disease-free survival in stage IA patients. We used propensity score case matching to minimize the bias due to imbalanced group comparisons.

resultsDuring the perioperative period, 1 death (0.4%) in group S and 7 (0.3%) in group L occurred. The hospital stay for the 2 groups was similar (median, 5.0 vs 5.0 days; range, 2-99 vs 2-58). The mean overall and disease-free survival period of those with T1a after segmentectomy or lobectomy seemed to be similar (4.2 vs 4.5 years, P=.06; and 4.1 vs 4.4 years, P=.07, respectively). Compared with segmentectomy, lobectomy yielded marginally significantly better overall (4.4 vs 3.9 years, P=.05) and disease-free (4.1 vs 3.6 years; P=.05) survival in those with T1b. We did not find a significantly different effect on the PFTs after segmentectomy or lobectomy.

conclusionsBoth surgical types were safe. We would advocate lobectomy for patients with stage IA disease, especially those with T1b. A retrospective study with a large sample size and more detailed information should be conducted for PFT evaluation, with additional stratification by lobe and laterality.

Indexed as

AgedFemaleHumansLength of StayLung NeoplasmsMaleNeoplasm StagingPneumonectomyPostoperative ComplicationsRespiratory Function TestsRetrospective StudiesRisk FactorsSurvival RateThoracic Surgery, Video-AssistedTreatment Outcome

Identifiers

PMID24746994
PMCPMC4169754
OpenAlexW2029969290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.